Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis to launch Atopica for Cats

Novartis Animal Health is to launch a treatment for chronic allergic dermatitis in cats after receiving regulatory approval in the US and EU. Atopica for Cats (cyclosporine) will be the first medication approved in both markets specifically for allergic dermatitis in cats. Novartis introduced a similar product to treat atopic dermatitis in dogs in 2002.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP001686

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel